PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients
Year: 2015
Type: article
Study design: Observational Study
Authors: Anna Koumarianou, Georgia Karayannopoulou, Georgia Gourgioti, Anna Batistatou, Mattheos Bobos, Ioannis Efstratiou, Dimosthenis Miliaras, Eleni Galani, George Pentheroudakis, Dimitrios Pectasides, Gerasimos Aravantinos, Dimitrios Bafaloukos, Pavlos Papakostas, Evangelia Razis, Haralabos P. Kalofonos, Kalliopi Petraki, Maria Sotiropoulou, Konstantine T. Kalogeras, George Fountzilas
Institutions: University General Hospital Attikon, Aristotle University of Thessaloniki, Hellenic Cooperative Oncology Group, University of Ioannina, Papageorgiou General Hospital, Metropolitan Hospital, University Hospital of Ioannina, Hippocration General Hospital, Hygeia Hospital, University of Patras, General University Hospital of Patras, Alexandra Hospital
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W280448161
